MedTrace Logo

Effect of Pectin in Chronic Kidney Disease Patients ( Stage 3 and 4 )

NCT06531993 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2024-08-01

No results posted yet for this study

Summary

Effect of pectin in chronic kidney disease patients

Conditions

  • Chronic Kidney Diseases

Interventions

DRUG

Pectin

Using pectin as tablets 600 mg per day for 6 months

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ashraf Anwer Thabet · Prof

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-31
Primary Completion
2025-03-31
Completion
2025-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06531993 on ClinicalTrials.gov